Layer-by-layer polymer coated gold nanoparticles for topical delivery of imatinib mesylate to treat melanoma

Molecular Pharmaceutics

Volumn 12, Issue 3, 2015, Pages 878-888

  Labala, Suman ^a   Mandapalli, Praveen Kumar ^a   Kurumaddali, Abhinav ^a   Venuganti, Venkata Vamsi Krishna ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

B16F10 cells; gold nanoparticles; imatinib mesylate; iontophoresis; layer by layer coating; topical delivery

Indexed keywords

GOLD NANOPARTICLE; IMATINIB; POLYETHYLENEIMINE; POLYMER; POVIDONE; ANTINEOPLASTIC AGENT; BIOMATERIAL; DRUG CARRIER; GOLD; METAL NANOPARTICLE; NANOCAPSULE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; IN VITRO STUDY; IONTOPHORESIS; MELANOMA; MELANOMA CELL; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SKIN PENETRATION; STRATUM CORNEUM; SURFACE PLASMON RESONANCE; ZETA POTENTIAL; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; INFRARED SPECTROSCOPY; INTRADERMAL DRUG ADMINISTRATION; MELANOMA, EXPERIMENTAL; METABOLISM; MOUSE; PATHOLOGY; PHARMACEUTICS; PIG; SKIN; TUMOR CELL LINE;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTINEOPLASTIC AGENTS; BIOPHARMACEUTICS; CELL LINE, TUMOR; CELL SURVIVAL; COATED MATERIALS, BIOCOMPATIBLE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; GOLD; IMATINIB MESYLATE; IN VITRO TECHNIQUES; IONTOPHORESIS; MELANOMA, EXPERIMENTAL; METAL NANOPARTICLES; MICE; NANOCAPSULES; POLYMERS; SKIN; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PLASMON RESONANCE; SUS SCROFA;

EID: 84923923595     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp5007163     Document Type: Article

References (50)

1. Wiedersberg, S.; Richard, H. G. Transdermal drug delivery: 30+ years of war and still fighting! J. Controlled Release 2014, 190, 150-156
2. Elias, P. M.; Friend, D. S. The permeability barrier in mammalian epidermis J. Cell Biol. 1975, 65, 180-191
3. Barry, B. W. Model mechanisms and devices to enable successful transdermal drug delivery Eur. J. Pharm. Sci. 2001, 14, 101-114
4. Williams, A. C.; Barry, B. W. Penetration enhancers Adv. Drug Delivery Rev. 2004, 56, 603-618
5. Prausnitz, M. R.; Langer, R. Transdermal drug delivery Nat. Biotechnol. 2008, 26, 1261-1268
6. Marro, D.; Kalia, Y. N.; Delgado-Charro, M. B.; Guy, R. H. Contributions of electromigration and electroosmosis to iontophoretic drug delivery Pharm. Res. 2001, 18, 1701-1708
7. Pikal, M. J. The role of electroosmotic flow in transdermal iontophoresis Adv. Drug Delivery Rev. 2001, 46, 281-305
8. Schneider, M.; Stracke, F.; Hansen, S.; Schaefer, U. F. Nanoparticles and their interactions with the dermal barrier Derm.-Endocrinol. 2009, 4, 197-206
9. Prow, T. W.; Grice, J. E.; Lin, L. L.; Faye, R.; Butler, M.; Becker, W.; Wurm, E. M. T.; Yoong, C.; Robertson, T. A.; Soyer, H. T.; Roberts, M. S. Nanoparticles and microparticles for skin drug delivery Adv. Drug Delivery Rev. 2011, 63, 470-491
10. Campbell, C. S.; Contreras-Rojas, L. R.; Delgado-Charro, M. B.; Guy, R. H. Objective assessment of nanoparticle disposition in mammalian skin after topical exposure J. Controlled Release 2012, 162, 201-207
11. Labouta, H. I.; Schneider, M. Interaction of inorganic nanoparticles with the skin barrier: current status and critical review Nanomedicine 2013, 9, 39-54
12. Mieszawska, A. J.; Mulder, W. J. M.; Fayad, Z. A.; Cormode, D. P. Multifunctional gold nanoparticles for diagnosis and therapy of disease Mol. Pharmaceutics 2013, 10, 831-847
13. Filon, F. L.; Crosera, M.; Adami, G.; Bovenzi, M.; Rossi, F.; Maina, G. Human skin penetration of gold nanoparticles through intact and damaged skin Nanotoxicology 2011, 5, 493-501
14. Huang, Y.; Yu, F.; Park, Y. S.; Wang, J.; Shin, M. C.; Chung, H. S.; Yang, V. C. Co-administration of protein drugs with gold nanoparticles to enable percutaneous delivery Biomaterials 2010, 31, 9086e9091
15. Zheng, D.; Giljohanna, D. A.; Chenc, D. L.; Massich, M. D.; Wang, X. Q.; Iordanovc, H.; Mirkina, C. A.; Paller, A. S. Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation Proc. Natl. Acad. Sci. U.S.A. 2012, 109, 11975-11980
16. Asadishad, B.; Vossoughi, M.; Alamzadeh, I. In vitro release behavior and cytotoxicity of doxorubicin-loaded gold nanoparticles in cancerous cells Biotechnol. Lett. 2010, 32, 649-654
17. Kim, B.; Han, G.; Toley, B. J.; Kim, C.; Rotello, V. M.; Forbes, N. S. Tuning payload delivery in tumour cylindroids using gold nanoparticles Nat. Nanotechnol. 2010, 5, 465-472
18. Tournebize, J.; Schneider, R. I.; Boudier, A.; Minet, A. S.; Maincent, P.; Leroy, P. Role of gold nanoparticles capping density on stability and surface reactivity to design drug delivery platforms ACS Appl. Mater. Interfaces 2012, 4, 5790-5799
19. Wyman, K.; Atkins, M. B.; Prieto, V.; Eton, O.; McDermott, D. F.; Hubbard, F.; Byrnes, C.; Sanders, K.; Sosman, J. A. Multicenter phase II trial of high-dose imatinib mesylate in metastatic melanoma Cancer 2006, 106, 2005-2011
20. Ghosh, S. K.; Pal, T. Interparticle coupling effect on the surface plasmon resonance of gold nanoparticles: from theory to applications Chem. Rev. 2007, 107, 4797-4862
21. Dreaden, E. C.; Alkilany, A. M.; El-Sayed, M. A.; Huang, X.; Murphy, C. J. The golden age: gold nanoparticles for biomedicine Chem. Soc. Rev. 2012, 41, 2740-2779
22. Auffan, M.; Rose, J.; Wiesner, M. R.; Bottero, J. Y. Chemical stability of metallic nanoparticles: a parameter controlling their potential cellular toxicity in-vitro Environ. Pollut. 2009, 157, 1127-1133
23. Kaufman, E. D.; Ricks, L. J.; Feldoto, Z.; Belyea, J.; Shah, P. K.; Blomberg, E.; Johnson, M. C.; Bayless, M.; Claesson, P.; Nicholson, Z. M.; Pettersson, T.; Franzen, S. Probing Protein adsorption onto mercaptoundecanoic acid stabilized gold nanoparticles and surfaces by quartz crystal microbalance and zeta-potential measurements Langmuir 2007, 23, 6053-6062
24. Zhu, T.; Vasilev, K.; Kreiter, M.; Mittler, S.; Knoll, W. Surface modification of citrate-reduced colloidal gold nanoparticles with 2-mercaptosuccinic acid Langmuir 2003, 19, 9518-9525
25. Zhang, S.; Leem, G.; Srisombat, L.; Lee, T. R. Rationally designed ligands that Inhibit the aggregation of large gold nanoparticles in solution J. Am. Chem. Soc. 2008, 130, 113-120
26. Mei, B. C.; Oh, E.; Susumu, K.; Farrell, D.; Mountziaris, T. J.; Mattoussi, H. Effects of ligand coordination number and surface curvature on the stability of gold nanoparticles in aqueous solutions Langmuir 2009, 25, 10604-10611
27. Baptista, P.; Pereira, E.; Eaton, P.; Doria, G.; Miranda, A.; Gomes, I.; Quaresma, P.; Franco, R. Gold nanoparticles for the development of clinical diagnosis methods Anal. Bioanal. Chem. 2008, 391, 943-950
28. Mandapalli, P. K.; Labala, S.; Vanamala, D.; Koranglekar, M. P.; Sakimalla, L. A.; Venuganti, V. V. Influence of charge on encapsulation and release behavior of small molecules in self-assembled layer-by-layer microcapsules Drug Delivery 2014, 21, 605-614
29. Kim, B. S.; Park, P. S.; Hammond, P. T. Hydrogen bonding layer by layer assembled biodegradable polymeric micelles as drug delivery vehicles from surfaces ACS Nano 2008, 2, 386-392
30. Oh, K. S.; Kim, R. S.; Lee, J.; Kim, D.; Cho, S. H.; Yuk, S. H. Gold/chitosan/pluronic composite nanoparticles for drug delivery J. Appl. Polym. Sci. 2008, 108, 3239-3244
31. Gangwar, R. K.; Dhumale, V. A.; Kumari, D.; Nakate, U.; Sharma, R. B.; Kale, S. N.; Datar, S.; Gosavi, S. W. Conjugation of curcumin with PVP capped gold nanoparticles for improving bioavailability Mater. Sci. Eng., C 2012, 32, 2659-2663
32. Oliveira, R.; Zhao, P.; Li, N.; Maria, L. C.; Vergnaud, J.; Ruiz, J.; Astruc, D.; Barratt, G. Synthesis and in vitro studies of gold nanoparticles loaded with docetaxel Int. J. Pharm. 2013, 454, 703-711
33. Venkatesan, R.; Pichaimani, A.; Balasubramanian, P. K.; Kumpati, P.; Hari, K.; Kulandaive, J. Doxorubicin conjugated gold nanorods: a sustained drug delivery carrier for improved anticancer therapy J. Mater. Chem. B 2013, 1, 1010-1018
34. Venkatpurwar, V.; Shiras, A.; Pokharkar, V. Porphyran capped gold nanoparticles as a novel carrier for delivery of anticancer drug: In-vitro cytotoxicity study Int. J. Pharm. 2011, 409, 314-320
35. Wang, F.; Wang, Y. C.; Dou, S.; Xiong, M. H.; Sun, T. M.; Wang, J. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells ACS Nano 2011, 5, 3679-3692
36. Naik, A.; Kalia, Y. N.; Guy, R. H. Transdermal drug delivery: overcoming the skin's barrier function Pharm. Sci. Technol. Today 2000, 3, 318-326
37. Baroli, B.; Ennas, M. G.; Loffredo, F.; Isola, M.; Pinna, R.; Lopez-Quintela, M. A. Penetration of metallic nanoparticles in human full-thickness skin J. Invest. Dermatol. 2007, 127, 1701-1712
38. Venuganti, V. V.; Sahdev, P.; Hildreth, M.; Guan, X.; Perumal, O. Structure-skin permeability relationship of dendrimers Pharm. Res. 2011, 28, 2246-2260
39. Kim, K. B.; Eton, O.; Davis, D. W.; Frazier, M. L.; McConkey, D. J.; Diwan, A. H.; Papadopoulos, N. E.; Camacho, L. H.; Ross, M. I.; Gershenwald, J. E.; Lee, J. E.; Mansfield, P. F.; Billings, L. A.; Bar-Eli, M.; Johnson, M. M.; Murgo, A. J.; Prieto, V. G. Phase II trial of imatinib mesylate in patients with metastatic melanoma Br. J. Cancer 2008, 99, 734-740
40. Guo, J.; Si, L.; Kong, Y.; Flaherty, K. T.; Xu, X.; Zhu, Y.; Corless, C. L.; Li, L.; Li, H.; Sheng, X.; Cui, C.; Chi, Z.; Li, S.; Han, M.; Mao, L.; Li, X.; Du, N.; Zhan, X.; Li, J.; Wang, B.; Qin, S. Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-kit mutation or amplification J. Clin. Oncol. 2011, 29, 2904-2909
41. Shukla, R.; Bansal, V.; Chaudhary, M.; Basu, A.; Bhonde, R. R.; Sastry, M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview Langmuir 2005, 2, 10644-10654
42. Moghimi, S. M.; Symonds, P.; Murray, J. C.; Hunter, A. C.; Debska, G.; Szewczyk, A. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy Mol. Ther. 2005, 11, 990-995
43. Thomas, M.; Ge, Q.; Lu, J. J.; Chen, J.; Klibanov, A. Cross-linked small polyethylenimines: while still nontoxic, deliver DNA efficiently to mammalian cells in vitro and in vivo Pharm. Res. 2005, 22, 373-380
44. Elbakry, A.; Wurster, E. C.; Zaky, A.; Liebl, R.; Schindler, E.; Bauer-Kreisel, P.; Blunk, T.; Rachel, R.; Goepferich, A.; Breunig, A. Layer-by-layer coated gold nanoparticles: size-dependent delivery of DNA into cells Small 2012, 8, 3847-3856
45. Song, W. J.; Du, J. Z.; Sun, T. M.; Zhang, P. Z.; Wang, J. Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery Small 2010, 6, 239-246
46. Ghannoum, M.; Lavergne, V.; Yue, C. S.; Ayoub, P.; Perreault, M. M.; Roy, L. Successful treatment of lithium toxicity with sodium polystyrene sulfonate: a retrospective cohort study Clin. Toxicol. 2010, 48, 34-41
47. Thomas, M.; Klibanov, A. M. Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 14640-14645
48. Yang, S.; May, S. Release of cationic polymer-DNA complexes from the endosome: A theoretical investigation of the proton sponge hypothesis J. Chem. Phys. 2008, 129, 185105-1-185105-9
49. Ojea-Jimenez, I.; Garcia-Fernandez, L.; Lorenzo, J.; Puntes, V. F. Facile preparation of cationic gold nanoparticle-bioconjugates for cell penetration and nuclear targeting ACS Nano 2012, 6, 7692-7702
50. Nativo, P.; Prior, I. A.; Brust, M. Uptake and intracellular fate of surface-modified gold nanoparticles ACS Nano 2008, 2, 1639-1644